Clinical Trial

Xanthohumol Metabolism and Signature

Study Description

Xanthohumol Metabolism and Signature

A pilot study to assess the safety and tolerability of oral xanthohumol in humans, to identify a biological signature of xanthohumol exposure, and to characterize the role of xanthohumol metabolism by intestinal microorganisms in that signature.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Xanthohumol

The xanthohumol supplement will be administered in a capsule. Participants in the experimental arm will consume the capsule once per day, with the first meal. The intervention will extend for 8 weeks.

Drug - Placebo oral capsule

The placebo (vehicle) will be administered in a capsule. Participants in the placebo arm will consume the capsule once per day, with the first meal.

Additional Information

Official Study Title

Xanthohumol Metabolism and Signature (XMaS) in Healthy Adults

Clinical Trial ID

NCT03735420

ParticipAid ID

av2Yra